WPRIM Management System> DCMS> Chinese Journal of Nephrology> 2014>

Volume:

1. Effect of long session hemodialysis on the quality of life in maintenance hemodialysis patients Page:747—751
2. Association of pro-hepcidin with inflammation and iron metabolism in hemodialysis patients with erythropoietin resistance Page:752—756
3. Association of residual renal function at initiation of dialysis with prognosis in maintenance dialysis patients Page:757—764
4. Analysis of risk factor of acute kidney injury after craniocerebral injury Page:765—768
5. Causes analysis of 652 hospital stays in patients with autosomal dominant polycystic kidney disease Page:769—774
6. A meta-analysis of hemoglobin target for anemia of patients with chronic kidney disease Page:775—779
7. Association of MYH9 gene single nucleotide polymorphism with clinic,pathology and prognosis of IgA nephropathy patients among Han nationality population in Inner Mongolia Page:780—784
8. Preliminary study of microRNA related to renal interstitial fibrosis in rats Page:785—789
9. Role of SARA in renal tubular epithelial to mesenchymal transition in diabetic nephropathy and its associated mechanism Page:790—797
10. Effect of angiotensin 1-7 on renal tubulointerstitial fibrosis of diabetic rats Page:798—803
11. Protection of NGAL on renal tubular epithelial cells in rat renal ischemia reperfusion injury Page:804—807
12. Effect of hyperbaric oxygen treatment on the expression of FasL and caspase-3 in renal tissue after renal ischemia reperfusion injury Page:808—812
13. Fluvastatin attenuates the down-regulation of β1 integrin expression in PAN-treated podocytes by inhibiting ROS Page:829—834
14. Early autophagy activation inhibits podocytes from apoptosis induced by aldosterone Page:835—839
15. Protective effect of Sunset Abelmoschus on podocyte injury in adriamycin-induced nephropathy rats Page:840—844
16. Clinicopathological and genetic feathers of 14 Fabry nephropathy patients Page:909—915
17. Efficacy,safety and tolerance of continuous erythropoietin receptor activator intravenous administration on anemia correction in dialysis patients with chronic renal anemia Page:847—852
18. Functional MR imaging of kidneys in patients with lupus nephritis Page:853—856
19. Detection of urinary α1-antitrypsin for predicting response to glucocorticoid therapy in children with primary nephrotic syndrome Page:857—862
20. Incidence and influencing factors of aldosterone breakthrough during therapy with angiotensin Ⅱ receptor blockers alone,or combined with angiotensin-converting enzyme inhibitors in patients with non-diabetic nephropathy Page:863—867
21. Expression of core-binding factor alpha 1 and collagen Ⅱ in patients with chronic kidney disease stage 5 Page:868—872
22. Protective mechanism of NALP3-siRNA on rat renal tubular epithelial cells from hypoxia/reoxygenation injury Page:873—878
23. Effect of estrogen on regression of vascular calcification in rats Page:879—882
24. Effect of histone acetylate modification on the plasminogen activator inhibitor 1 gene regulation in mesangial cells Page:883—887
25. Effect and mechanism of fluvastatin on the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysate Page:888—893
26. Effects of triptolide on proliferation and apoptosis in rat mesangial cells induced by transforming growth factor β1 and related mechanisms Page:894—899
27. Association of radial arterial calcification damage with bone mineral density and bone metabolism biomarkers in uremia patients Page:916—921
28. Expression of parathyroid hormone in renal tissues of patients with early stage chronic kidney disease and its role in renal lesions Page:922—926
29. Meta-analysis of N-acetylcysteine on prevention of contrast-induced nephropathy Page:927—932
30. Analysis of associated factors in secondary hyperparathyroidism of continuous ambulatory peritoneal dialysis patients Page:933—936
31. Analysis on urinary system lesions of IgG4-related disease Page:937—942
32. Effect of regulating endoplasmic reticulum stress on the expression of SET7/9 in the kidneys of db/db mice with diabetic nephropathy Page:943—949
33. Effect of high glucose on glomerular endothelial-mesenchymal transition and its possible mechanism Page:950—955
34. Effect of hepatitis B virus X gene on transdifferentiation of human proximal tubular epithelial cells Page:956—960
35. Recombinant human erythropoietin as a novel agent with pleiotropic effects against sepsis-induced acute kidney injury Page:961—967
36. Angiotensin Ⅱ promotes the expression of glomerular IQGAP1 and apoptosis of glomerular cells Page:27—32
37. Correlation of M-type phospholipase A2 receptor genetic polymorphism with idiopathic membranous nephropathy Page:1—5
38. Value of urinary L-FABP and NGAL in the diagnosis of acute kidney injury caused by obstructive nephropathy and the prediction of renal outcome Page:21—26
39. Low-density lipoprotein promotes epithelial-mesenchymal transition and extracellular matrix accumulation in human peritoneal mesothelial cells Page:44—49
40. Effect of hepatitis B virus X gene on apoptosis and immune molecules of renal tubular epithelial cells Page:50—54
41. Typing of amyloidosis in renal biopsies of 205 cases Page:88—92
42. Prognostic comparison of patients starting peritoneal dialysis within two weeks and more than two weeks after catheter implantation Page:93—97
43. Significance of serum troponin T and C-reactive protein in the long-term prognosis of hemodialysis patients Page:108—113
44. Comparison of two nephrotic syndrome rat models Page:137—141
45. Correlation between glycosylated hemoglobin and carotid intima-media thickness in non-diabetic peritoneal dialysis patients Page:169—172
46. Effect of endoplasmic reticulum stress on the activation of high glucose-induced monocytes Page:189—194
47. Effect of MG132 on the expression of ERK1/2 and connective tissue growth factor in rat peritoneal mesothelial cells induced by high glucose Page:195—198
48. Impact of ischemic preconditioning on dynamics of homing of endothelial progenitor cells after renal ischemia reperfusion injury Page:199—203
49. Epidemiology investigation of initial hemodialysis patients in Shanxi province during 2010-2011 Page:6—10
50. Features of ambulatory blood pressure in 540 patients with chronic kidney disease Page:11—15
51. Effects of benazepril on the expressions of intergrin-linked kinase and α-smooth muscle actin in glomerular mesangial cells exposed to high glucose Page:33—38
52. Impact of visit-to-visit variability in blood pressure on renal function of stage 3-4 chronic kidney diseases patients with hypertension Page:98—102
53. Effect of suramin on the epithelial-mesenchymal transition in peritoneal mesothelial cells induced by high concentration glucose Page:142—146
54. Validation of cystatin C-based equations for evaluation of residual renal function among patients undergoing continuous ambulatory peritoneal dialysis Page:178—182
55. High glucose induces endothelial-to-chondrocyte transition in human aortic endothelial cells Page:183—188
56. Skeletal muscle wasting in diabetic kidney disease rats and the effect of low-protein diet combined with a-keto acids Page:204—209
57. Effect of angiotensin Ⅱ type 1 receptor blocker on the 12-lipoxygenase activity and P-cadherin expression in type 2 diabetic rat glomeruli Page:210—215
58. Effect of gender matching on the outcomes of living-donor renal transplantation Page:243—247
59. Meta-analysis of tacrolimus and cyclophosphamide in the treatment of lupus nephritis Page:248—252
60. Effect of erythropoietin on the oriented chemotaxis of bone-marrow mesenchymal stem cells under acute kidney injury microenvironment Page:263—267
61. Effects of silibinin on expression of integrin linked kinase, transforming growth factor β1 and α-smooth muscle actin in rat peritoneal mesothelial cells induced by high glucose Page:268—272
62. Effect of cysteine-rich protein 61 on proliferation and cell cycle in human renal tubular epithelial cells Page:273—276
63. Angiotensin Ⅱ induces lipid accumulation in human renal proximal tubular epithelial cells via the disruption of low density lipoprotein receptor pathway Page:293—297
64. The difference of ELISA and LABScreen in detecting HLA antibodies Page:321—325
65. A study on the change of autophagy in skeletal muscle of patients with chronic kidney disease Page:333—338
66. Relationship between hemoglobin variability and prognosis in dialysis patients Page:253—257
67. Lanthanum carbonate vs conventional phosphate binders for the treatment of hyperphosphatemia in maintenance hemodialysis patients: a meta-analysis Page:339—346
68. Effect of Cordyceps sinensis on renal fibrosis in 5/6 subtotal nephrectomy rats and its possible mechanism Page:347—351
69. Effect of adrenomedullin on rat renal tubular epithelial cell apoptosis induced by hypoxia-reoxygenation and its mechanism Page:358—363
70. Effect of calcium phosphate crystals induced by uremic serum on calcification of human aortic smooth muscle cells Page:364—369
71. Role of transforming growth factor β1 in the process of histone acetylate modification of plasminogen activator inhibitor 1 gene in mesangial cells Page:370—374
72. The application status of vascular access at initiation of hemodialysis in patients with end stage renal disease-a single center study Page:897—902
73. The influence of serum 25(OH)D levels on abnormal glucose metabolism induced by glucocorticoid in renal glomerular disease patients Page:891—896
74. Human umbilical cord mesenchymal stem cells co-culture ameliorates podocytic apoptosis：a possible role of HGF Page:933—938
75. DC-SIGN expression on podocytes and its role in immune and inflammatory responses of lupus nephritis Page:925—932
76. Effect of aldosterone receptor antagonist on obesity-related glomerulonephropathy Page:919—924
77. Survival of analysis of older patients with external iliac vein tunneled cuffed catheters on maintenance hemodialysis Page:913—918
78. Influence of reversed dipper blood pressure pattern on target organ damage in patients with chronic kidney disease Page:907—912
79. Association of metabolic syndrome and chronic kidney disease among Uygur adults in Moyu country in Xinjiang Uygur Autonomous Region Page:903—906

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.